SelectScience InterviewsClinical Diagnostics
Precision Medicine and the Future of Clinical Cancer Genomics
12 Aug 2019
In this presentation at the European Society of Human Genetics (ESHG) conference 2019, Dr. Susie Cooke, Head of Genetics at Glasgow Precision Oncology Laboratory, University of Glasgow, UK, introduces Precision Panc, a UK-wide pancreatic cancer clinical trials network that translates cutting-edge concepts in cancer biology into genomic assays and analytical pathways. Cooke discusses the challenges and opportunities of applying high-throughput genomics to routine oncology care pathways and how this could influence the future of precision medicine.